Medication info

Phenofibrate Tablets (Fenofibrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Fenofibrate›160mg / 1 tablet
Manufacturer / importer
(Yoo) Hanpung Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
100 tablets/PTP[(10 tablets/PTP)×10]
Approval status
Expired

MFDS item code 201905903 · Approved 2019.08.21

This product's status changed to Expired on 2024.08.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of primary hyperlipidemia (such as hypercholesterolemia and hypertriglyceridemia)
Who takes it
Adults · Children
Adult dose
○ Adults : Administer fenofibrate 160 mg orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This drug may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients : Dose reduction is generally not necessary if renal function is not decreased. ○ Patients with renal impairment : Do not administer this drug to patients with moderate to severe renal impairment (serum creatinine level 2.5 mg/dL or higher).
Child dose
○ Pediatric patients : Clinical data on the use of this drug in pediatric patients are not yet available.

Ingredients

Manufacturer
(Yoo) Hanpung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of primary hyperlipidemia (such as hypercholesterolemia and hypertriglyceridemia)

  • Hypercholesterolemia
  • hypertriglyceridemia
View approved original text

Primary hyperlipidemia refers to various forms of lipid disorders that include hypercholesterolemia and hypertriglyceridemia. It is primarily classified into type IIa, IIb, type III, and type IV, which correspond to hypercholesterolemia, a complex of cholesterol and triglycerides, and hypertriglyceridemia, respectively. This medication is used to treat primary hyperlipidemia by regulating blood lipid levels.

How to take

Adult dose

○ Adults : Administer fenofibrate 160 mg orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This drug may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients : Dose reduction is generally not necessary if renal function is not decreased. ○ Patients with renal impairment : Do not administer this drug to patients with moderate to severe renal impairment (serum creatinine level 2.5 mg/dL or higher).

Child dose

○ Pediatric patients : Clinical data on the use of this drug in pediatric patients are not yet available.

Precautions

This medication should not be used in patients with poor liver function. It should also be used cautiously in patients with moderate to severe renal impairment, as it may lead to severe muscle damage known as rhabdomyolysis. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Patients who are allergic to this medication or any of its ingredients should also avoid it. It is advisable that patients with gallbladder issues or a history of gallstone formation, as well as those who have previously experienced photoallergic or phototoxic reactions, refrain from using this medication. This medication is not intended for children. Since this medication contains lactose, patients with genetic conditions such as lactose intolerance, lactose enzyme deficiency, or glucose-galactose malabsorption should not take it. Patients with slight renal impairment or a past history of kidney issues should use this medication carefully, possibly with reduced dosage or prolonged intervals, and must be closely monitored due to the risk of rhabdomyolysis. Patients with abnormal liver function or a history of liver problems should regularly conduct liver function tests while on this medication. Patients on anticoagulants, the elderly, and those with a history of gallstones need careful management when taking this medication. This medication can affect the liver or bile ducts, potentially causing elevated liver enzyme levels or leading to gallstones, hepatitis, and cirrhosis, necessitating regular liver function tests. Skin reactions like rashes or itching, sensitivity to sunlight, and occasionally hair loss may occur. Neurological symptoms such as dizziness, headache, weakness, and peripheral neuropathy may also present. There is a risk of thromboembolism, and there may be elevations in muscle pain, muscle cramps, and related test values, so patients should consult their doctor immediately if symptoms arise. Gastrointestinal issues such as abdominal pain, nausea, vomiting, diarrhea, and bloating may occur, and in some cases, pancreatitis may arise. Respiratory problems, decreased blood cell counts, and renal function deterioration are also rarely reported. This medication may interact with other drugs, especially with statins, anticoagulants, and hypoglycemic agents, so patients should consult their physician or pharmacist when taking these medications together. Pregnant or nursing women are advised not to take this medication. The elderly are at a higher risk of decreased liver and kidney function, so caution is necessary. In cases of overdose, there is no specific antidote, making it important to adhere strictly to the prescribed dosage, keeping it out of reach of children.

Side effects

  • elevated serum aminotransferases
  • hepatic enlargement
  • cholestatic hepatitis
  • gallstones
  • rash
  • itching
  • photosensitivity reactions
  • alopecia
  • weakness
  • hyperthermia
Show 28 more
  • dizziness
  • headache
  • peripheral neuropathy
  • thromboembolism
  • elevated creatine kinase
  • myalgia
  • muscle cramps
  • arthralgia
  • rhabdomyolysis
  • urticaria
  • phototoxic eczema
  • gastrointestinal disturbances
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • abdominal bloating
  • pancreatitis
  • convulsion abnormalities
  • decreased hemoglobin
  • leukopenia
  • eosinophilia
  • elevated serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmias
  • fatigue
  • erectile dysfunction
  • weight gain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C. Proper storage can help maintain the medication’s effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

100 tablets/PTP[(10 tablets/PTP)×10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.